Literature DB >> 31100380

Many Patients With Irritable Bowel Syndrome Have Atypical Food Allergies Not Associated With Immunoglobulin E.

Annette Fritscher-Ravens1, Theresa Pflaum2, Marie Mösinger2, Zino Ruchay2, Christoph Röcken3, Peter J Milla4, Melda Das2, Martina Böttner5, Thilo Wedel5, Detlef Schuppan6.   

Abstract

BACKGROUND & AIMS: Confocal laser endomicroscopy (CLE) is a technique that permits real-time detection and quantification of changes in intestinal tissues and cells, including increases in intraepithelial lymphocytes and fluid extravasation through epithelial leaks. Using CLE analysis of patients with irritable bowel syndrome (IBS), we found that more than half have responses to specific food components. Exclusion of the defined food led to long-term symptom relief. We used the results of CLE to detect reactions to food in a larger patient population and analyzed duodenal biopsy samples and fluid from patients to investigate mechanisms of these reactions.
METHODS: In a prospective study, 155 patients with IBS received 4 challenges with each of 4 common food components via the endoscope, followed by CLE, at a tertiary medical center. Classical food allergies were excluded by negative results from immunoglobulin E serology analysis and skin tests for common food antigens. Duodenal biopsy samples and fluid were collected 2 weeks before and immediately after CLE and were analyzed by histology, immunohistochemistry, reverse transcription polymerase chain reaction, and immunoblots. Results from patients who had a response to food during CLE (CLE+) were compared with results from patients who did not have a reaction during CLE (CLE-) or healthy individuals (controls).
RESULTS: Of the 108 patients who completed the study, 76 were CLE+ (70%), and 46 of these (61%) reacted to wheat. CLE+ patients had a 4-fold increase in prevalence of atopic disorders compared with controls (P = .001). Numbers of intraepithelial lymphocytes were significantly higher in duodenal biopsy samples from CLE+ vs CLE- patients or controls (P = .001). Expression of claudin-2 increased from crypt to villus tip (P < .001) and was up-regulated in CLE+ patients compared with CLE- patients or controls (P = .023). Levels of occludin were lower in duodenal biopsy samples from CLE+ patients vs controls (P = .022) and were lowest in villus tips (P < .001). Levels of messenger RNAs encoding inflammatory cytokines were unchanged in duodenal tissues after CLE challenge, but eosinophil degranulation increased, and levels of eosinophilic cationic protein were higher in duodenal fluid from CLE+ patients than controls (P = .03).
CONCLUSIONS: In a CLE analysis of patients with IBS, we found that more than 50% of patients could have nonclassical food allergy, with immediate disruption of the intestinal barrier upon exposure to food antigens. Duodenal tissues from patients with responses to food components during CLE had immediate increases in expression of claudin-2 and decreases in occludin. CLEpatients also had increased eosinophil degranulation, indicating an atypical food allergy characterized by eosinophil activation.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diet; Eosinophil; Food Allergy; Tight Junction

Mesh:

Substances:

Year:  2019        PMID: 31100380     DOI: 10.1053/j.gastro.2019.03.046

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  42 in total

1.  Does a Minority of Children With Functional Gastrointestinal Disorders Receive Formal Diet Advice?

Authors:  Ligia Alfaro Cruz; Charles Minard; Danielle Guffey; Bruno P Chumpitazi; Robert J Shulman
Journal:  JPEN J Parenter Enteral Nutr       Date:  2020-02-04       Impact factor: 4.016

2.  Allergies and Irritable Bowel Syndrome.

Authors:  Nicholas J Talley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-11

Review 3.  Evidence-based and mechanistic insights into exclusion diets for IBS.

Authors:  Paul Moayyedi; Magnus Simrén; Premysl Bercik
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-03-02       Impact factor: 46.802

Review 4.  Immune activation in irritable bowel syndrome: what is the evidence?

Authors:  Javier Aguilera-Lizarraga; Hind Hussein; Guy E Boeckxstaens
Journal:  Nat Rev Immunol       Date:  2022-03-16       Impact factor: 53.106

Review 5.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

Review 6.  Best management of irritable bowel syndrome.

Authors:  Christopher J Black; Alexander Charles Ford
Journal:  Frontline Gastroenterol       Date:  2020-05-28

7.  Anxiety-like behavior and intestinal microbiota changes as strain-and sex-dependent sequelae of mild food allergy in mouse models of cow's milk allergy.

Authors:  Nicholas A Smith; Danielle L Germundson; Pan Gao; Junguk Hur; Angela M Floden; Kumi Nagamoto-Combs
Journal:  Brain Behav Immun       Date:  2021-03-09       Impact factor: 19.227

8.  Butyrate Alleviates Cytokine-Induced Barrier Dysfunction by Modifying Claudin-2 Levels.

Authors:  Xinyi Huang; Tadayuki Oshima; Toshihiko Tomita; Hirokazu Fukui; Hiroto Miwa
Journal:  Biology (Basel)       Date:  2021-03-09

Review 9.  Update on the Role of Allergy in Pediatric Functional Abdominal Pain Disorders: A Clinical Perspective.

Authors:  Craig Friesen; Jennifer Colombo; Jennifer Schurman
Journal:  Nutrients       Date:  2021-06-16       Impact factor: 5.717

10.  The Natural History of Chronic Unexplained Gastrointestinal Disorders and Gastroesophageal Reflux During 20 Years: A US Population-Based Study.

Authors:  Rok Seon Choung; Yuri A Saito; Cathy D Schleck; William S Harmsen; Alan R Zinsmeister; Joseph A Murray; Nicholas J Talley
Journal:  Mayo Clin Proc       Date:  2021-03       Impact factor: 11.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.